Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Inventory (2019 - 2025)

Bioadaptives' Inventory history spans 7 years, with the latest figure at $44706.0 for Q4 2025.

  • Quarterly results put Inventory at $44706.0 for Q4 2025, up 133.88% from a year ago — trailing twelve months through Dec 2025 was $44706.0 (up 133.88% YoY), and the annual figure for FY2025 was $44706.0, up 133.88%.
  • Inventory for Q4 2025 was $44706.0 at Bioadaptives, up from $44228.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $44706.0 in Q4 2025 to a low of $3572.0 in Q1 2022.
  • The 5-year median for Inventory is $10647.0 (2022), against an average of $16577.5.
  • The sharpest move saw Inventory crashed 70.93% in 2022, then skyrocketed 559.57% in 2025.
  • Year by year, Inventory stood at $4750.0 in 2021, then surged by 86.88% to $8877.0 in 2022, then skyrocketed by 72.14% to $15281.0 in 2023, then increased by 25.09% to $19115.0 in 2024, then surged by 133.88% to $44706.0 in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $44706.0, $44228.0, and $39574.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.